FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chantal Truffot-Pernot

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Anatomy

Spleen
Lung

Physiology

Microbial Drug Resistance

Co-author Network

Publications

TOP 3
C Bernard; F Brossier; A Fournier; Vincent Jarlier; S Larnaudie; J Robert; W Sougakoff; Chantal Truffot-Pernot; F Antoun; Nicolas Veziris
Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris.
F Brossier; Nicolas Veziris; Chantal Truffot-Pernot; Vincent Jarlier; Wladimir Sougakoff
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Murad Ibrahim; Chantal Truffot-Pernot; Koen Andries; Vincent Jarlier; Nicolas Veziris
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chantal Truffot-Pernot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: C Bernard; F Brossier; A Fournier; Vincent Jarlier; S Larnaudie; J Robert; W Sougakoff; Chantal Truffot-Pernot; F Antoun; Nicolas Veziris
Impact of a 14-year screening programme on tuberculosis transmission among the homeless in Paris.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012;16(5):649-55.
2011: F Brossier; Nicolas Veziris; Chantal Truffot-Pernot; Vincent Jarlier; Wladimir Sougakoff
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 2011;55(1):355-60.
2009: Murad Ibrahim; Chantal Truffot-Pernot; Koen Andries; Vincent Jarlier; Nicolas Veziris
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.
American journal of respiratory and critical care medicine 2009;180(6):553-7.
2007: Marie-Laure Uffredi; Chantal Truffot-Pernot; Bertrand Dautzenberg; Muriel Renard; Vincent Jarlier; Jérôme Robert
An intervention programme for the management of multidrug-resistant tuberculosis in France.
International journal of antimicrobial agents 2007;29(4):434-9.
2007: M Ibrahim; Koen Andries; Nacer Lounis; Aurélie Chauffour; Chantal Truffot-Pernot; Vincent Jarlier; Nicolas Veziris
Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis.
Antimicrobial agents and chemotherapy 2007;51(3):1011-5.
2006: Stéphanie Matrat; Nicolas Veziris; Claudine MAYER; Vincent Jarlier; Chantal Truffot-Pernot; Juliette Camuset; Elisabeth Bouvet; Emmanuelle Cambau; Alexandra Aubry
Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
Antimicrobial agents and chemotherapy 2006;50(12):4170-3.
2006: Nicolas Veziris; Alexandra Aubry; Chantal Truffot-Pernot
[Trends in tuberculosis treatment duration].
Presse médicale (Paris, France : 1983) 2006;35(11 Pt 2):1758-64.
2006: Chantal Truffot-Pernot; Nicolas Véziris; Wladimir Sougakoff
[Modern diagnosis of tuberculosis].
Presse médicale (Paris, France : 1983) 2006;35(11 Pt 2):1739-46.
2006: Nacer Lounis; Nicolas Veziris; Aurélie Chauffour; Chantal Truffot-Pernot; Koen Andries; Vincent Jarlier
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration.
Antimicrobial agents and chemotherapy 2006;50(11):3543-7.
2006: Florence Brossier; Nicolas Veziris; Chantal Truffot-Pernot; Vincent Jarlier; Wladimir Sougakoff
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.
Journal of clinical microbiology 2006;44(10):3659-64.
2006: Céline Pulcini; Eric Vandenbussche; Isabelle Podglajen; Wladimir Sougakoff; Chantal Truffot-Pernot; Annie Buu-Hoï; Emmanuelle Varon; Jean-Luc Mainardi
Hip prosthesis infection due to Mycobacterium wolinskyi.
Journal of clinical microbiology 2006;44(9):3463-4.
2006: Norin Chai; Lionel Deforges; Wladimir Sougakoff; Chantal Truffot-Pernot; Amaury de Luze; Barbara A Demeneix; Marie Clément; Marie Claude Bomsel
Mycobacterium szulgai infection in a captive population of African clawed frogs (Xenopus tropicalis).
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 2006;37(1):55-8.
2006: Alexandra Aubry; Nicolas Veziris; Emmanuelle Cambau; Chantal Truffot-Pernot; Vincent Jarlier; L Mark Fisher
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Antimicrobial agents and chemotherapy 2006;50(1):104-12.
2005: Nicolas Veziris; Nacer Lounis; Aurélie Chauffour; Chantal Truffot-Pernot; Vincent Jarlier
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.
Antimicrobial agents and chemotherapy 2005;49(10):4015-9.
2005: N Valin; F Antoun; C Chouaïd; M Renard; Bertrand Dautzenberg; Valérie Lalande; B Ayache; P Morin; Wladimir Sougakoff; J M Thiolet; Chantal Truffot-Pernot; Vincent Jarlier; Bénédicte Decludt
Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(5):528-33.
2005: Koen Andries; Peter Verhasselt; Jérôme Guillemont; Hinrich Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven E Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.
Science (New York, N.Y.) 2005;307(5707):223-7.
2004: Lionel Deforges; Henri-Jean Boulouis; Jean-Laurent Thibaud; Lilia Boulouha; Wladimir Sougakoff; S Blot; Glyn Hewinson; Chantal Truffot-Pernot; N Haddad
First isolation of Mycobacterium microti (Llama-type) from a dog.
Veterinary microbiology 2004;103(3-4):249-53.
2004: Wladimir Sougakoff; M Rodrigue; Chantal Truffot-Pernot; M Renard; N Durin; M Szpytma; R Vachon; Alain Troesch; Vincent Jarlier
Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(4):289-94.
2004: Nicolas Veziris; Alexandra Aubry; Wladimir Sougakoff; Chantal Truffot-Pernot; Vincent Jarlier
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections].
Médecine tropicale : revue du Corps de santé colonial 2004;64(3):243-9.
2003: J Robert; D Trystram; Chantal Truffot-Pernot; Vincent Jarlier
Multidrug-resistant tuberculosis: eight years of surveillance in France.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003;22(5):833-7.
2003: Nicolas Veziris; Chantal Truffot-Pernot; Alexandra Aubry; Vincent Jarlier; Nacer Lounis
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo.
Antimicrobial agents and chemotherapy 2003;47(10):3117-22.
2003: Nacer Lounis; C Maslo; Chantal Truffot-Pernot; Jacques H Grosset; R J Boelaert
Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(6):575-9.
2003: Valérie Zeller; Anne-Lyse Nardi; Chantal Truffot-Pernot; Wladimir Sougakoff; Bruno Stankoff; Christine Katlama; François Bricaire
Disseminated infection with a mycobacterium related to Mycobacterium triplex with central nervous system involvement associated with AIDS.
Journal of clinical microbiology 2003;41(6):2785-7.
2003: Jean-Noël Dauendorffer; Isabelle Guillemin; Alexandra Aubry; Chantal Truffot-Pernot; Wladimir Sougakoff; Vincent Jarlier; Emmanuelle Cambau
Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.
Journal of clinical microbiology 2003;41(3):1311-5.
2001: Nacer Lounis; Abdelhalim Bentoucha; Chantal Truffot-Pernot; Baohong Ji; RJ O'Brien; Andrew Vernon; G Roscigno; Jacques H Grosset
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 2001;45(12):3482-6.
2001: Nacer Lounis; Chantal Truffot-Pernot; Abdelhalim Bentoucha; Jérôme Robert; Baohong Ji; Jacques H Grosset
Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice.
Antimicrobial agents and chemotherapy 2001;45(11):3229-30.
2001: Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset; Victor Roland Gordeuk; Johan R Boelaert
Iron and Mycobacterium tuberculosis infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2001;20(3):123-6.
2000: Emmanuelle Cambau; Chantal Truffot-Pernot; F Boulahbal; C Wichlacz; Jacques H Grosset; V Jarlier
Mycobacterial growth indicator tube versus the proportion method on Löwenstein-Jensen medium for antibiotic susceptibility testing of Mycobacterium tuberculosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2000;19(12):938-42.
2000: A Aubry; V Jarlier; S Escolano; Chantal Truffot-Pernot; Emmanuelle Cambau
Antibiotic susceptibility pattern of Mycobacterium marinum.
Antimicrobial agents and chemotherapy 2000;44(11):3133-6.
2000: J Robert; D Trystram; Chantal Truffot-Pernot; B Carbonnelle; Jacques H Grosset
Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(7):665-72.
2000: J Robert; D Trystram; Chantal Truffot-Pernot; Emmanuelle Cambau; Vincent Jarlier; Jacques H Grosset
Twenty-five years of tuberculosis in a French university hospital: a laboratory perspective.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(6):504-12.
2000: N Daniel; Nacer Lounis; Baohong Ji; RJ O'Brien; Andrew Vernon; Geiter Lawrence; M Szpytma; Chantal Truffot-Pernot; G Hejblum; Jacques H Grosset
Antituberculosis activity of once-weekly rifapentine-containing regimens in mice. Long-term effectiveness with 6- and 8-month treatment regimens.
American journal of respiratory and critical care medicine 2000;161(5):1572-7.
1999: J Robert; F Boulahbal; D Trystram; Chantal Truffot-Pernot; Anne-Claire De Benoist; V Vincent; Vincent Jarlier; Jacques H Grosset
A national survey of human Mycobacterium bovis infection in France. Network of Microbiology Laboratories in France.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(8):711-4.
1999: Nadine Lemaitre; Wladimir Sougakoff; Chantal Truffot-Pernot; Vincent Jarlier
Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.
Antimicrobial agents and chemotherapy 1999;43(7):1761-3.
1999: Emmanuelle Cambau; C Wichlacz; Chantal Truffot-Pernot; Vincent Jarlier
Evaluation of the new MB redox system for detection of growth of mycobacteria.
Journal of clinical microbiology 1999;37(6):2013-5.
1998: Anne Carbonne; Nadine Lemaitre; M Bochet; Chantal Truffot-Pernot; C Katlama; Jacques H Grosset; F Bricaire; Vincent Jarlier
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facility.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19(10):784-6.
1998: Baohong Ji; Nacer Lounis; C Maslo; Chantal Truffot-Pernot; Pascale Bonnafous; Jacques H Grosset
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1998;42(8):2066-9.
1998: N Lemaître; Wladimir Sougakoff; Chantal Truffot-Pernot; Emmanuelle Cambau; J P Derenne; F Bricaire; Jacques H Grosset; Vincent Jarlier
Use of DNA fingerprinting for primary surveillance of nosocomial tuberculosis in a large urban hospital: detection of outbreaks in homeless people and migrant workers.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1998;2(5):390-6.
1998: Jacques H Grosset; Nacer Lounis; Chantal Truffot-Pernot; RJ O'Brien; M C Raviglione; Baohong Ji
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.
American journal of respiratory and critical care medicine 1998;157(5 Pt 1):1436-40.
1998: Jacques H Grosset; Chantal Truffot-Pernot
[Mycobacterium xenopi, a newcomer?].
La Revue du praticien 1998;48(7):701-3.
1997: B Wyplosz; Chantal Truffot-Pernot; J Robert; Vincent Jarlier; Jacques H Grosset
[The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
Revue des maladies respiratoires 1997;14 Suppl 5():S33-48.
1997: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.
Antimicrobial agents and chemotherapy 1997;41(5):1168-9.
1997: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?
Antimicrobial agents and chemotherapy 1997;41(3):607-10.
1997: Bertrand Dautzenberg; Chantal Truffot-Pernot; J Hazebroucq; S Legris; C Guérin; C Begelman; G Guermonprez; M H Fievet; C Chastang; Jacques H Grosset
A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections.
Infection 1997;25(1):16-21.
1996: Bertrand Dautzenberg; P Castellani; J L Pellegrin; D Vittecoq; Chantal Truffot-Pernot; N Pirotta; D Sassella
Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.
Antimicrobial agents and chemotherapy 1996;40(7):1722-5.
1996: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?
Antimicrobial agents and chemotherapy 1996;40(2):437-42.
1995: Chantal Truffot-Pernot; Nacer Lounis; Jacques H Grosset; Baohong Ji
Clarithromycin is inactive against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(12):2827-8.
1995: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy 1995;39(6):1341-4.
1995: Bertrand Dautzenberg; D Piperno; P Diot; Chantal Truffot-Pernot; J P Chauvin
Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.
Chest 1995;107(4):1035-40.
1995: Nacer Lounis; Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.
Antimicrobial agents and chemotherapy 1995;39(3):608-12.
1994: Emmanuelle Cambau; Wladimir Sougakoff; M Besson; Chantal Truffot-Pernot; Jacques H Grosset; Vincent Jarlier
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(5):1351.
1994: L Chapuis; Baohong Ji; Chantal Truffot-Pernot; R J O'Brien; M C Raviglione; Jacques H Grosset
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.
American journal of respiratory and critical care medicine 1994;150(5 Pt 1):1355-62.
1994: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model.
Antimicrobial agents and chemotherapy 1994;38(11):2521-9.
1994: Emmanuelle Cambau; Wladimir Sougakoff; M Besson; Chantal Truffot-Pernot; Jacques H Grosset; Vincent Jarlier
Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.
The Journal of infectious diseases 1994;170(2):479-83.
1994: B Heym; Nadine Honoré; Chantal Truffot-Pernot; A Banerjee; Catherine Schurra; William R. Jacobs Jr.; Jan D A Van Embden; Jacques H Grosset; Stewart T Cole
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.
Lancet 1994;344(8918):293-8.
1994: Chantal Truffot-Pernot; Emmanuelle Cambau
[Bacteriological diagnosis of tuberculosis].
Revue de pneumologie clinique 1994;50(5):240-6.
1993: Baohong Ji; Chantal Truffot-Pernot; C Lacroix; M C Raviglione; R J O'Brien; P Olliaro; G Roscigno; Jacques H Grosset
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice.
The American review of respiratory disease 1993;148(6 Pt 1):1541-6.
1993: V Lalande; Chantal Truffot-Pernot; A Paccaly-Moulin; Jacques H Grosset; Baohong Ji
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.
Antimicrobial agents and chemotherapy 1993;37(3):407-13.
1992: Baohong Ji; Nacer Lounis; Chantal Truffot-Pernot; Jacques H Grosset
Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy.
Antimicrobial agents and chemotherapy 1992;36(12):2839-40.
1992: Jacques H Grosset; Chantal Truffot-Pernot; C Lacroix; Baohong Ji
Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Antimicrobial agents and chemotherapy 1992;36(3):548-51.
1991: Baohong Ji; Chantal Truffot-Pernot; Jacques H Grosset
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.
Tubercle 1991;72(3):181-6.
1991: Chantal Truffot-Pernot; Baohong Ji; Jacques H Grosset
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.
Antimicrobial agents and chemotherapy 1991;35(8):1677-8.
1991: Chantal Truffot-Pernot; Baohong Ji; Jacques H Grosset
Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments.
Tubercle 1991;72(1):57-64.
1989: H F Lecoeur; Chantal Truffot-Pernot; Jacques H Grosset
Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
The American review of respiratory disease 1989;140(5):1189-93.
1989: Chantal Truffot-Pernot; H F Lecoeur; L Maury; Bertrand Dautzenberg; Jacques H Grosset
Results of blood cultures for detection of mycobacteria in AIDS patients.
Tubercle 1989;70(3):187-91.
1989: H F Lecoeur; P H Lagrange; Chantal Truffot-Pernot; M Gheorghiu; Jacques H Grosset
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice.
Clinical and experimental immunology 1989;76(3):458-62.
1988: Jacques H Grosset; Chantal Truffot-Pernot; H Lecoeur
[New and future drugs in pulmonary tuberculosis].
Praxis und Klinik der Pneumologie 1988;42 Suppl 1():206-10.
1988: Chantal Truffot-Pernot; A M Giroir; L Maury; Jacques H Grosset
[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Revue des maladies respiratoires 1988;5(4):401-6.
1985: Jacques H Grosset; Chantal Truffot-Pernot; S Poggi; H Lecoeur; C Chastang
[Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
Revue des maladies respiratoires 1985;2(4):205-8.
1983: Jacques H Grosset; Chantal Truffot-Pernot; H Lecoeur; C C Guelpa-Lauras
[Activity of rifampicin administered daily and intermittently on experimental tuberculosis in mice].
Pathologie-biologie 1983;31(5):446-50.
1983: Chantal Truffot-Pernot; Jacques H Grosset; R Bismuth; H Lecoeur
[Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
Revue française des maladies respiratoires 1983;11(6):875-82.